###begin article-title 0
Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging Agents
###end article-title 0
###begin p 1
###xml 324 348 324 348 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 324 348 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The mechanistic and therapeutic differences in the cellular response to DNA-damaging compounds are not completely understood, despite intense study. To expand our knowledge of DNA damage, we assayed the effects of 12 closely related DNA-damaging agents on the complete pool of ~4,700 barcoded homozygous deletion strains of Saccharomyces cerevisiae. In our protocol, deletion strains are pooled together and grown competitively in the presence of compound. Relative strain sensitivity is determined by hybridization of PCR-amplified barcodes to an oligonucleotide array carrying the barcode complements. These screens identified genes in well-characterized DNA-damage-response pathways as well as genes whose role in the DNA-damage response had not been previously established. High-throughput individual growth analysis was used to independently confirm microarray results. Each compound produced a unique genome-wide profile. Analysis of these data allowed us to determine the relative importance of DNA-repair modules for resistance to each of the 12 profiled compounds. Clustering the data for 12 distinct compounds uncovered both known and novel functional interactions that comprise the DNA-damage response and allowed us to define the genetic determinants required for repair of interstrand cross-links. Further genetic analysis allowed determination of epistasis for one of these functional groups.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin title 3

###end title 3
###begin p 4
Cells have evolved sophisticated ways to respond to DNA damage. This is critical because unrepaired damage can kill cells or cause them to become cancerous. The response to DNA damage has been studied for more than 50 years, and has been found to be extremely complex. The traditional way of understanding this complexity is to divide the process into its component parts with the goal of eventually reconstituting the entire process. In this study, the authors extend classical approaches using genomics-an approach that involves studying all genes in an organism simultaneously. The authors tested 12 distinct compounds (many used in cancer chemotherapy) that damage DNA and uncovered new genes involved in DNA repair. They then grouped the compounds to define how they attack cells. Using this approach, the study found that many similar DNA-damaging agents act in comparable ways to damage DNA, but surprisingly, similar compounds can also act on cells by very different mechanisms. Specifically grouping the findings together and verifying the significant results lends a high degree of confidence in the data. The development of such a reproducible experimental design is important for inspiring future experiments.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 282 283 282 283 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b01">1</xref>
###xml 499 500 499 500 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b02">2</xref>
###xml 501 502 501 502 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b03">3</xref>
###xml 636 637 636 637 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b04">4</xref>
###xml 638 639 638 639 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b05">5</xref>
Eukaryotic cells possess multiple mechanisms to cope with structural damage to their DNA. For example, nucleotide excision repair (NER) excises oligonucleotides containing a covalently modified base and resynthesizes the deleted fragment using the undamaged DNA strand as template [1]. Cell-cycle checkpoints respond to damaged DNA by initiating a series of phosphorylation and dephosphorylation events that result in a transient arrest of the cell cycle, providing time for lesions to be repaired [2,3]. During DNA replication, multiple pathways ensure the stability and restarting of stalled replication forks at sites of DNA damage [4,5]. The sum total of these activities and similar functional repair "modules" are commonly referred to as the DNA-damage response (DDR).
###end p 6
###begin p 7
###xml 299 300 299 300 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b06">6</xref>
###xml 301 302 301 302 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b07">7</xref>
###xml 448 449 448 449 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b08">8</xref>
###xml 677 678 677 678 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b09">9</xref>
###xml 135 138 <span type="species:ncbi:9606">man</span>
The study of gene products and pathways that comprise the DDR has particular relevance to both the etiology and treatment of cancer in man. A causative role for the DDR in carcinogenesis is supported by several observations, including the high degree of genomic instability observed in tumor cells [6,7] and the number of DDR genes that, when mutated, lead to cancer or to one of several inherited disorders characterized by cancer predisposition [8]. Therapeutically, many cytotoxic agents used to treat cancer act by directly targeting DNA. Therefore, pathways that actively repair DNA lesions are likely to contribute to the significant problem of clinical drug resistance [9].
###end p 7
###begin p 8
###xml 257 281 257 281 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 452 454 452 454 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b10">10</xref>
###xml 455 457 455 457 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b11">11</xref>
###xml 679 681 679 681 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b12">12</xref>
###xml 682 684 682 684 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b18">18</xref>
###xml 108 113 <span type="species:ncbi:4932">yeast</span>
###xml 207 210 <span type="species:ncbi:9606">man</span>
###xml 257 281 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 566 571 <span type="species:ncbi:4932">yeast</span>
The high degree of conservation between the genes and pathways involved in maintaining genetic integrity in yeast and all metazoans supports the use of model organisms to better understand these pathways in man. Indeed, classical forward genetic screens in Saccharomyces cerevisiae have led to the identification of several genes important for responding to DNA damage, providing the parts list from which the current framework of the DDR has emerged [10,11]. The results of these screens have been augmented by the recent disruption and barcoding of each predicted yeast open reading frame which has proven to be a powerful tool in identifying additional components of the DDR [12-18].
###end p 8
###begin p 9
###xml 42 44 42 44 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b19">19</xref>
###xml 45 47 45 47 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b22">22</xref>
###xml 94 107 94 107 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 218 225 218 225 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t001">Table 1</xref>
###xml 94 107 <span type="species:ncbi:4932">S. cerevisiae</span>
In this study, we used fitness profiling [19-22] to interrogate a pooled collection of ~4,700 S. cerevisiae homozygous deletion strains for sensitivity to 12 agents known to compromise the structural integrity of DNA (Table 1). Fitness analysis of individual deletion strains identified in these global experiments confirmed our microarray data and revealed that the genetic requirements for resistance to DNA-damaging agents may exceed previous estimates. We discovered that those strains sensitive to these compounds carried deletions primarily in genes known to be involved in DNA metabolism, but we also uncovered genes not previously known to be related to the DDR. While resistance to a given compound typically required multiple DDR modules, we found that the relative importance of these modules was varied, even when comparing functionally related compounds. The significance of our results are 4-fold: (1) we developed a robust exportable assay to identify and confirm DDR components; (2) filtering and clustering the data allowed classification of both the mechanism of drug action and gene function; (3) we used epistasis analysis to identify novel functional relationships between DDR components; and (4) we were able to clearly discriminate the genome-wide response to agents that damage DNA by forming interstrand cross-links (ICLs) from those that do not.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 25 30 <span type="species:ncbi:4932">Yeast</span>
Fitness Profiling of the Yeast Deletion Collection
###end title 11
###begin p 12
###xml 165 167 165 167 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b13">13</xref>
###xml 168 170 168 170 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b16">16</xref>
###xml 171 173 171 173 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b20">20</xref>
###xml 174 176 174 176 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b22">22</xref>
###xml 177 179 177 179 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b24">24</xref>
###xml 300 302 300 302 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b12">12</xref>
###xml 303 305 303 305 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b14">14</xref>
###xml 306 308 306 308 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b16">16</xref>
###xml 309 311 309 311 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b18">18</xref>
###xml 312 314 312 314 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b25">25</xref>
###xml 315 317 315 317 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b27">27</xref>
###xml 890 897 890 897 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t001">Table 1</xref>
###xml 927 929 927 929 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b22">22</xref>
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast deletion collection is a powerful tool for identifying genes important for fitness on a genome-wide scale under a diverse set of environmental conditions [13,16,20,22-24]. This resource has been particularly valuable in the study of cellular mechanisms that respond to DNA-damaging agents [12-14,16,18,25-27]. Each of these studies has provided new insights into the DDR. The underlying protocols in these well-executed studies are, however, so disparate that they preclude any direct comparisons beyond general conclusions. For example, some studies were performed on solid media, while others used high doses of compound followed by recovery in liquid media. Furthermore, the data analysis varies from study to study. To provide a consistent and comprehensive dataset of the DDR, we (1) profiled 12 unique DNA-damaging compounds (six of which had not previously been profiled) (Table 1) using a validated protocol [22]; (2) confirmed a subset of our microarray fitness data by individual strain analysis; and (3) where possible, correlated our results with previously published studies. Specifically, we sought to detect mechanistic differences between compounds that form ICLs (cisplatin, oxaliplatin, carboplatin, mechlorethamine, mitomycin C, and psoralen) and those that do not (angelicin, 4-nitroquinoline-1-oxide [4-NQO], 2-dimethylaminoethyl chloride [2-DMAEC], methyl methanesulfonate [MMS], streptozotocin, and camptothecin).
###end p 12
###begin p 13
###xml 533 554 533 554 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 556 566 556 566 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd001">Dataset S1</xref>
###xml 568 579 568 579 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd006">Protocol S1</xref>
In our experiments, ~4,700 homozygous diploid deletion mutants were grown in pooled cultures in the presence of compound. Cells were then collected, genomic DNA purified, and the unique molecular barcodes present in each strain amplified by PCR and hybridized to an oligonucleotide array carrying the barcode complements. The relative fitness of each strain was then determined by comparing the signal intensity for each strain on the microarray to the corresponding intensities obtained from a series of no-drug control arrays (see Materials and Methods; Dataset S1; Protocol S1).
###end p 13
###begin title 14
Validating the Approach by Individual Strain Confirmation
###end title 14
###begin p 15
###xml 371 392 371 392 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 585 595 585 595 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd002">Dataset S2</xref>
###xml 597 608 597 608 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd007">Protocol S2</xref>
###xml 611 619 611 619 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g001">Figure 1</xref>
###xml 927 948 927 948 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1093 1101 1093 1101 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g001">Figure 1</xref>
###xml 1151 1152 1151 1152 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1152 1153 1152 1153 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1164 1165 1164 1165 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1315 1316 1315 1316 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1316 1317 1316 1317 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1328 1329 1328 1329 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1674 1695 1674 1695 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s4">Materials and Methods</xref>
Little experimental evidence directly addresses how well fitness defects or sensitivities measured by microarray analysis correlate with actual growth rates of individually cultured strains. To directly address this issue, we cultured the 233 deletion strains most sensitive to mechlorethamine individually (as determined from three replicate microarray experiments, see Materials and Methods). The individual growth rates of these strains were measured, both in the presence and absence of mechlorethamine, by taking optical-density readings of liquid cultures every 15 min for 30 h (Dataset S2; Protocol S2). Figure 1A shows representative growth curves for 32 of these cultures (16 in dimethyl sulfoxide [DMSO, diluent control] and 16 in mechlorethamine). We defined the sensitivity to mechlorethamine of each strain by calculating the difference between the average doubling time (AvgG) in DMSO and in mechlorethamine (see Materials and Methods). These values were then normalized to wild-type and plotted against their corresponding fitness-defect scores as measured from the microarray (Figure 1B). We observed a highly significant correlation (R2 = 0.5086, p = 8.5e-38; data not shown). When we removed strains exhibiting fitness defects in the absence of drug from the analysis, this correlation increased (R2 = 0.7462; p = 5.4e-57). This is consistent with slow-growing strains yielding artificially low fitness-defect scores in microarray-based fitness analysis of pooled cultures (see Overall Experimental Design). Of 233 individual strains analyzed, 206 exhibited significant mechlorethamine-dependent fitness defects compared to that of a wild-type strain (see Materials and Methods).
###end p 15
###begin p 16
###xml 174 176 174 176 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b28">28</xref>
###xml 177 179 177 179 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b29">29</xref>
###xml 311 318 311 318 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t002">Table 2</xref>
To further test how well our significance calling in our microarray experiments correlated with individual growth rates, we compared a calculated false-discovery rate (FDR) [28,29] with a measured FDR for the top 81 most sensitive strains according to the combined results for pooled growth in mechlorethamine (Table 2). The FDR calculation allows us to establish a fitness-defect score threshold for a given acceptable rate of false discovery. Specifically, we calculated the cut-off for several FDRs and examined the individual growth curves of strains that were designated as significant at these cut-offs. For example, the array results show that a 5% FDR cut-off results in 37 sensitive strains from the pooled experiments. The individual growth curves of these 37 strains reveal that 35 of them are indeed sensitive to mechlorethamine, giving us a 5.4% FDR (two out of 37). For this drug, our measured FDR is lower than the calculated FDR. It should be noted that although the above underscores the low FDR in our experiments, it can not address the extent of the false-negative rate.
###end p 16
###begin title 17
Overall Experimental Design
###end title 17
###begin p 18
###xml 421 423 421 423 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b22">22</xref>
As we refined our assay for the DNA-damaging agents, it became apparent that the length of time for which cells are exposed to compound has a dramatic effect on the sensitivity of deletion strains lacking those genes most required for growth. Specifically, in our standard assay design, frozen aliquots of the deletion collection are recovered in rich media for ten generations until they reach logarithmic growth phase [22]. Compound is then added and the culture is robotically grown for precisely 20 generations. This prolonged chronic exposure allows for detection of those gene products that are required for resistance even for those gene products that have small (<5%) growth defects. We used this standard assay to profile four compounds: mechlorethamine, cisplatin, streptozotocin, and camptothecin. The results of these experiments made it clear that any deletion strain exhibiting a slow-growth phenotype in the absence of compound becomes depleted from the pool even before the compound is applied. As a consequence, this experimental design precludes any meaningful measure of the fitness of this subset of strains. To circumvent this problem, we altered our experimental protocol in the following way: frozen pool aliquots were thawed and immediately exposed to compound for the equivalent of five generations of wild-type growth.
###end p 18
###begin p 19
###xml 243 250 243 250 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t001">Table 1</xref>
###xml 535 545 535 541 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad51&#916;</italic>
###xml 550 560 546 552 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad52&#916;</italic>
###xml 664 666 656 658 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b30">30</xref>
###xml 795 803 787 795 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g001">Figure 1</xref>
Control experiments showed no non-specific sensitivity of the wild-type strain as a result of cells recovering from a frozen state using this protocol (data not shown). This revised experimental design was used to screen the 12 compounds (see Table 1) because (1) this low number of generations minimizes the false-negative rate resulting from slow-growing strains; and (2) these experiments should identify gene products immediately required for resistance to compound. The advantages of this design are demonstrated by examining the rad51Delta and rad52Delta homozygous deletion strains, both of which are defective for homologous recombination-mediated repair [30]. Both are acutely sensitive to mechlorethamine but also exhibit a slow-growth phenotype in the absence of mechlorethamine (see Figure 1A). In the standard 20-generation assay, however, the fitness-defect scores of these deletion strains in mechlorethamine ranked 1,676 and 2,051, respectively, among the other ~4,700 strains in the pool (where the strain most sensitive to mechlorethamine has a rank of 1). When the revised experimental design was used, the average rank of these strains increased to 21 and 23, respectively. Therefore, in the former case, neither strain was sensitive, but in the latter case, both were extremely sensitive.
###end p 19
###begin p 20
###xml 385 393 385 393 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
###xml 480 487 480 487 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t003">Table 3</xref>
###xml 553 599 553 583 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(rad9&#916;, rad24&#916;, rad17&#916;, ddc1&#916;,</italic>
###xml 604 614 588 594 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">mec3&#916;)</italic>
###xml 847 855 826 834 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
###xml 880 889 859 864 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad9&#916;</italic>
###xml 894 904 869 875 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad24&#916;</italic>
###xml 1064 1066 1035 1037 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b31">31</xref>
###xml 1067 1069 1038 1040 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b32">32</xref>
###xml 1182 1190 1153 1161 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
###xml 1495 1517 1466 1480 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad17&#916;, ddc1&#916;,</italic>
###xml 1522 1532 1485 1491 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">mec3&#916;,</italic>
###xml 1611 1616 1570 1575 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD24</italic>
###xml 1635 1637 1594 1596 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b33">33</xref>
###xml 1678 1688 1637 1643 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad24&#916;</italic>
###xml 1697 1705 1652 1660 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
###xml 1873 1875 1828 1830 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b18">18</xref>
###xml 1876 1878 1831 1833 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b34">34</xref>
###xml 1879 1881 1834 1836 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b35">35</xref>
Despite our observation that the shorter-generation assay detected many DDR genes, comparing the five-generation assay with the standard 20-generation assay yielded additional insight. For example, there is an increase in strains that are deleted for genes classified as "other" or "unknown" that exhibit fitness defects only after extended exposure (i.e. 20 generations) to compound (Figure 2A). Particularly interesting examples are strains defective in DNA-damage checkpoints. Table 3 summarizes the average rank of five checkpoint-defective strains (rad9Delta, rad24Delta, rad17Delta, ddc1Delta, and mec3Delta) following five or 20 generations of pool growth in 500 muM cisplatin. We followed up on this result by monitoring the growth rate of these individual strains during the first five and second five generations of growth in cisplatin (Figure 2B). Strikingly, both the rad9Delta and rad24Delta strains exhibited accelerated growth relative to wild-type during the first five generations, consistent with a lack of checkpoint-mediated cell-cycle arrest [31,32]. Despite this accelerated growth, these strains exhibited reduced viability even at the five-generation point (Figure 2C). Consistent with this observation during the next five generations (6-10), these mutants did exhibit a reduced rate of growth, presumably due to the accumulation of DNA and chromosomal damage associated with uncontrolled progression through the cell cycle. Notably, the growth rate of deletion strains rad17Delta, ddc1Delta, and mec3Delta, whose protein products form a complex loaded onto DNA at sites of damage in a RAD24-dependent manner [33], were indistinguishable from that of a rad24Delta strain (Figure 2C; data not shown). These results may explain the discrepancy between conflicting reports that address the requirement of checkpoint genes for resistance to cisplatin [18,34,35].
###end p 20
###begin p 21
###xml 393 401 393 401 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-st001">Table S1</xref>
###xml 834 842 833 841 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
###xml 869 901 868 888 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">gcs1&#916;, swi4&#916;, rtf1&#916;,</italic>
###xml 906 916 893 899 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">yme1&#916;,</italic>
###xml 738 743 <span type="species:ncbi:4932">yeast</span>
In addition to checkpoint-defective strains, a number of other deletion strains exhibited sensitivity only after 20 generations of growth. These strains, however, do not exhibit accelerated growth at five generations but appear to be required only after long-term chronic exposure. These strains are deleted for genes that modify chromatin structure and are involved in the respiratory chain (Table S1). Despite the lack of an observable growth defect at five generations, we hypothesized that some of these strains, depending on the cause of their sensitivity, may have reduced viability. To test this, we plated serial dilutions of individual strains (that exhibited sensitivity after 20 generations, but not after five generations) on yeast extract/peptone/dextrose (YPD) following five generations of growth in 500 muM cisplatin (Figure 2C). Of the four we tested, gcs1Delta, swi4Delta, rtf1Delta, and yme1Delta, none showed an increased loss of viability. Liquid cultures of these strains confirmed these results, as a decrease in growth rate compared to wild-type is only observed at later-generation time points, and is not observed at the five-generation time point.
###end p 21
###begin title 22
Interstrand DNA Cross-Linkers
###end title 22
###begin p 23
###xml 305 312 305 312 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t001">Table 1</xref>
###xml 390 392 390 392 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b36">36</xref>
###xml 555 557 555 557 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b37">37</xref>
###xml 683 685 683 685 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b38">38</xref>
###xml 758 760 758 760 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b39">39</xref>
In this study, we examined the effects of a variety of DNA-damaging agents, but placed particular emphasis on compounds that induce cross-links between complementary strands of DNA (the ICLs). Even though each of the six ICL-inducing compounds we profiled cause a variety of structural damage to DNA (see Table 1), the cytotoxic effects of these compounds are attributed primarily to ICLs [36]. These compounds differ in the efficacy with which they induce ICLs, ranging from 30-40% of all lesions for psoralen to 1-5% of all lesions for mechlorethamine [37]. They also differ in their preferred substrates. Mitomycin C, for example, typically cross-links guanines at CpG sequences [38], whereas psoralen predominantly cross-links thymines at TpA sequences [39].
###end p 23
###begin p 24
###xml 182 184 182 184 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b18">18</xref>
###xml 185 187 185 187 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b35">35</xref>
###xml 188 190 188 190 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b40">40</xref>
###xml 282 307 282 307 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD2, RAD4, RAD10, RAD1,</italic>
###xml 312 319 312 319 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD14),</italic>
###xml 324 359 324 359 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD57, RAD55, RAD51, RAD52, RAD54,</italic>
###xml 364 371 364 371 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD59),</italic>
###xml 380 393 380 393 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD6, RAD18,</italic>
###xml 398 403 398 403 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD5)</italic>
###xml 500 508 500 508 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g003">Figure 3</xref>
###xml 842 850 842 850 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g003">Figure 3</xref>
###xml 899 921 899 921 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s5">Supporting Information</xref>
###xml 54 59 <span type="species:ncbi:4932">yeast</span>
Previous studies have suggested that ICL tolerance in yeast can be attributed to three major pathways: NER, homologous recombination repair (HRR), and post-replication repair (PRR) [18,35,40]. Our results corroborate these findings as strains carrying deletions in genes of the NER (RAD2, RAD4, RAD10, RAD1, and RAD14), HRR (RAD57, RAD55, RAD51, RAD52, RAD54, and RAD59), and PRR (RAD6, RAD18, and RAD5) pathways were found to be highly sensitive to each of the six ICL-inducing compounds we tested. Figure 3 depicts the relative requirement for each of several DNA-repair modules. Although the genes that make up these modules are somewhat arbitrarily assigned, we believe that they are generally acceptable in the DNA-damage community and, moreover, provide a simple visual depiction of some of the important differences between compounds. Figure 3 provides only an overview (for more detail, see Supporting Information). Examining the top 30 sensitive strains for a given compound and the relative sensitivity rankings for these strains gives a snapshot of the first line of defense against the damage induced by that compound. The gene groups with the lowest ranks contain genes that, when deleted, result in the greatest sensitivity to that drug and therefore are presumably most important in conferring resistance. Extending this list to the top 250 sensitive strains then begins to show a more general view of other DDR pathways that are also involved in responding to damage caused by that agent.
###end p 24
###begin p 25
###xml 151 159 151 159 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g003">Figure 3</xref>
###xml 594 603 594 599 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">pso2&#916;</italic>
###xml 879 883 875 879 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSO2</italic>
###xml 885 887 881 883 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b41">41</xref>
###xml 986 988 982 984 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b40">40</xref>
###xml 1185 1196 1181 1192 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV1, REV3,</italic>
###xml 1201 1206 1197 1202 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV7,</italic>
###xml 1241 1243 1237 1239 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b42">42</xref>
###xml 1244 1246 1240 1242 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b43">43</xref>
###xml 1256 1261 1252 1257 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSO2,</italic>
###xml 1350 1352 1346 1348 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b44">44</xref>
The genes from these pathways are also important for resistance to additional types of DNA damage, as is evidenced by the profiles of other compounds (Figure 3). Therefore, their sensitivity to cross-linking agents could be due to a combined deficiency in the repair of ICLs as well as other DNA lesions. To identify strains whose sensitivity was entirely due to a lack of ICL repair, we screened the compounds angelicin and 2-DMAEC, monofunctional analogues of psoralen and mechlorethamine, respectively. The most striking difference between these profiles was the relative sensitivity of the pso2Delta deletion strain, which ranked among the most sensitive strains in psoralen and mechlorethamine (and indeed all other cross-linking compounds), but which exhibited no detectable sensitivity to angelicin or 2-DMAEC. These observations are consistent with previous findings for PSO2 [41], whose protein product is thought to facilitate the repair of ICLs as a part of the NER pathway [40]. Further comparisons between ICL and non-ICL-inducing compounds underscored the importance of translesion DNA synthesis (TLS) to the repair of ICLs. This is consistent with previous findings for REV1, REV3, and REV7, which operate in a branch of PRR [42,43]. Unlike PSO2, however, the role of these genes in the DDR is unlikely to be restricted to ICL repair [44].
###end p 25
###begin p 26
###xml 503 517 503 517 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(MRE11, RAD50,</italic>
###xml 522 528 522 528 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">XRS2),</italic>
###xml 581 583 581 583 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b45">45</xref>
###xml 653 675 653 675 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s5">Supporting Information</xref>
###xml 708 713 708 713 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 718 723 718 723 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS4,</italic>
###xml 853 855 853 855 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b46">46</xref>
###xml 856 858 856 858 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b47">47</xref>
###xml 1268 1270 1268 1270 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b48">48</xref>
Of the six ICL-inducing compounds, carboplatin and mitomycin C resistance required a significantly larger number of genes whose biological function was not previously linked to DNA metabolism. Generally speaking, however, with respect to well-characterized DNA-damage-responsive pathways, there was a high level of correlation between the genetic requirements for resistance among the ICL-inducing compounds that we profiled. There were, however, some exceptions to this. Genes encoding the MRX complex (MRE11, RAD50, and XRS2), involved in the repair of DNA double-strand breaks [45], were particularly important for resistance to mechlorethamine (see Supporting Information). Strains deleted for the genes MUS81 and MMS4, whose protein products are thought to form a structure-specific endonuclease important for restarting stalled replication forks [46,47], were highly sensitive to each cross-linker with the exception of psoralen. Finally, resistance to carboplatin appeared less dependent on NER machinery when compared to other cross-linkers, including other members of the platinum family. This is surprising because the mechanism of action and the spectrum of clinical activity of cisplatin and carboplatin are more similar to each other than to oxaliplatin [48].
###end p 26
###begin title 27
Non-Cross-Linking DNA-Damaging Agents
###end title 27
###begin p 28
###xml 425 427 425 427 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b49">49</xref>
###xml 428 430 428 430 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b50">50</xref>
###xml 668 670 668 670 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b51">51</xref>
We also profiled five compounds that covalently modify DNA but do not induce ICLs. These included the aforementioned angelicin and 2-DMAEC, as well as streptozotocin, MMS, and 4-NQO. Streptozotocin and MMS are both clinically used cytotoxics that methylate DNA primarily at the N-7 position of guanine residues. They also generate, albeit at a lower frequency, the more toxic O-6 methylguanine and N-3 methyladenine adducts [49,50]. 4-NQO reacts with DNA to form several high-molecular-weight adducts including 3-(deoxyguanosine-N2-yl)-4-aminoquinoline-1-oxide, N-(deoxyguanosine-C8-yl)-4-aminoquinoline-1-oxide, and 3-(deoxyadenosine-N6-yl)-4-aminoquinoline-1-oxide [51].
###end p 28
###begin p 29
###xml 120 125 120 125 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 126 130 126 130 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS4</italic>
###xml 176 184 176 184 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g003">Figure 3</xref>
###xml 555 557 555 557 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b52">52</xref>
###xml 706 711 706 711 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MAG1,</italic>
###xml 764 766 764 766 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b53">53</xref>
###xml 767 769 767 769 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b54">54</xref>
###xml 873 877 873 877 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MAG1</italic>
The fitness profiles of these five DNA-modifying compounds were similar in so far as strains deficient in HRR, PRR, and MUS81/MMS4 exhibited sensitivity to all five compounds (Figure 3). This likely reflects a common ability of these compounds to cause lesions that impede the advancement of DNA-replication forks during S-phase. There were also several differences in the five fitness profiles. To remove DNA adducts, the cell can employ one of several excision-repair mechanisms, the selection of which is based on the size of the offending DNA adduct [52]. In agreement with this, we found that NER was important for resistance to compounds that cause bulkier DNA adducts (angelicin and 4-NQO), whereas MAG1, encoding a DNA glycosylase of base excision repair [53,54], was important for resistance to the methylating activities of streptozotocin and MMS. Interestingly, MAG1 appeared to be more important for resistance to MMS than to streptozotocin, based on rank.
###end p 29
###begin p 30
###xml 298 300 298 300 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b55">55</xref>
###xml 512 517 512 517 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 518 522 518 522 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS4</italic>
A sixth non-cross-linking agent profiled, camptothecin, is distinct from the other compounds in this study because it inhibits the activity of an enzyme rather than directly modifying DNA. Camptothecin inhibits the enzyme topoisomerase I (Top I), and stabilizes a covalent enzyme-DNA intermediate [55]. During replication, collision of the replication machinery with this protein-DNA complex causes double-strand breaks. Our assay revealed a unique sensitivity profile for camptothecin. Strains deficient in the MUS81/MMS4 complex and HRR showed the greatest sensitivity to camptothecin, as expected for a treatment that induces stalled replication forks. Neither PRR nor excision-repair mechanisms appeared to play a prominent role in conferring resistance to camptothecin.
###end p 30
###begin title 31
Uncharacterized Genes
###end title 31
###begin p 32
###xml 301 309 301 309 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-st002">Table S2</xref>
###xml 354 362 354 362 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YDR291W,</italic>
###xml 574 575 574 575 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 588 589 588 589 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</italic>
###xml 608 610 608 610 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b56">56</xref>
###xml 689 691 689 691 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b57">57</xref>
###xml 819 820 819 820 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 833 834 833 834 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</italic>
###xml 963 975 963 971 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ylr426w&#916;</italic>
###xml 1141 1142 1137 1138 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1155 1156 1151 1152 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</italic>
###xml 1165 1172 1161 1168 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YKL075C</italic>
###xml 1315 1331 1311 1327 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ashbya gossypii.</italic>
###xml 1402 1415 1398 1411 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 1438 1440 1434 1436 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b58">58</xref>
###xml 1441 1443 1437 1439 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b59">59</xref>
###xml 595 600 <span type="species:ncbi:9606">Human</span>
###xml 715 720 <span type="species:ncbi:4932">yeast</span>
###xml 798 803 <span type="species:ncbi:4932">yeast</span>
###xml 807 810 <span type="species:ncbi:9606">man</span>
###xml 842 847 <span type="species:ncbi:9606">human</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
###xml 1315 1330 <span type="species:ncbi:33169">Ashbya gossypii</span>
###xml 1402 1415 <span type="species:ncbi:4932">S. cerevisiae</span>
Of the 36 array experiments examined in this study, 283 strains scored significantly sensitive in at least one experiment when a 5% FDR threshold was used. Among these 283 strains, 87 are sensitive in three or more independent experiments and four of these strains contain deletions in unnamed genes (Table S2). The most notable of these four strains is YDR291W, a gene encoding a putative DNA helicase that appears to be involved in repairing mechlorethamine-induced lesions. The amino acid sequence of Ydr291w is conserved across many organisms, including mammals (BLASTP E-value = 3.0e-08 to Human RecQ4 [56]), and its proposed helicase function is due to its helicase sequence motifs [57]; the function of this yeast open reading frame is currently being tested. Ymr073c is also conserved from yeast to man (BLASTP E-value = 7.0e-09 to a human cytochrome oxidoreductase), and our results suggest it is involved in resistance to carboplatin and cisplatin. The ylr426wDelta deletion strain showed sensitivity in mechlorethamine and streptozotocin, and its protein product is similar to a human peptide annotated as a dehydrogenase (BLASTP E-value = 6.0e-05). The YKL075C mutant strain was sensitive in both streptozotocin and camptothecin at 20 generations of exposure, and is only conserved with another fungus, Ashbya gossypii. All four of these unnamed genes have detectable protein expression in S. cerevisiae (>50 molecules/cell) [58,59].
###end p 32
###begin p 33
###xml 556 560 556 560 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RMD7</italic>
###xml 675 677 675 677 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b60">60</xref>
###xml 795 801 795 801 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RTT101</italic>
###xml 878 889 878 889 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ELG1, MMS1,</italic>
###xml 894 900 894 900 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RTT107</italic>
###xml 907 911 907 911 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LTE1</italic>
###xml 957 959 957 959 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b61">61</xref>
###xml 960 962 960 962 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b62">62</xref>
###xml 1134 1136 1134 1136 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b63">63</xref>
###xml 1209 1217 1209 1217 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-st002">Table S2</xref>
The paucity of unnamed genes in our results is likely due to the stringency of the significance cut-off we used to minimize false positives as well as being a consequence of the level of attention that DNA-repair pathways have received. An equally important factor is the finding that many of the named genes do not properly reflect the complexity of their cellular roles. Specifically, many of the sensitive strains that carry three-letter names are poorly characterized and, more importantly, their roles in the DDR are largely unknown. For example, the RMD7 mutant appears sensitive to several cross-linking compounds yet is named for being required for meiotic division [60]. Other genes are better characterized, but thus far are only known to have functions not involved in the DDR (e.g., RTT101 [regulates Ty1 transposition, though other RTT genes are DDR genes, such as ELG1, MMS1, and RTT107], and LTE1 [essential for growth in low temperatures]) [61,62]. Overall, the 283 strains making the sensitivity cut-off in at least one experiment contain 34 strains deleted for genes with no functional annotation (by Gene Ontology [63]), and roughly half are annotated in processes unrelated to DNA repair (Table S2). Our results provide functional data that these genes are in fact involved in the DDR and suggest additional experiments to further characterize them.
###end p 33
###begin title 34
Global Analysis
###end title 34
###begin p 35
###xml 147 155 147 155 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
To analyze the 36 array experiments presented here in a global manner, we applied hierarchical clustering techniques to the fitness-defect scores (Figure 4A). The dataset used for clustering was restricted to strains designated as significant (5% FDR) in two or more of the array experiments, and thus represented only the most highly sensitive strains identified in this study. This produced a matrix of fitness-defect scores (141 strains x 36 experiments). An examination of the clusters across the experiment axis showed that, as expected, compounds predicted to have similar mechanisms of action group together, lending confidence in the robustness of the analysis. Members of the platinum family of compounds are highly correlated, as are MMS and streptozotocin, the only two agents profiled that possess DNA-methylating activity. The genome-wide data was highly reproducible, evidenced by the fact that all replicates correlate as nearest neighbors.
###end p 35
###begin p 36
###xml 201 209 201 209 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
###xml 393 401 393 401 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
When the clustered results are viewed along the gene axis, we predicted there would be a high correlation in fitness profiles between strains with deficiencies in genes in the same DNA-repair pathway (Figure 4B), and this prediction was confirmed. This result holds true for several DNA-repair epistasis groups, including NER, PRR, HRR, error-prone TLS, and cell-cycle checkpoint control (see Figure 4A).
###end p 36
###begin p 37
###xml 158 181 158 181 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1, SHU1, SHU2, CSM2,</italic>
###xml 186 190 186 190 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3</italic>
###xml 355 357 355 357 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b64">64</xref>
###xml 358 360 358 360 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b65">65</xref>
###xml 363 367 363 367 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 432 434 432 434 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b66">66</xref>
###xml 553 555 553 555 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b67">67</xref>
###xml 619 623 619 623 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 781 785 781 785 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 976 980 976 980 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 999 1016 999 1016 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU1, SHU2, CSM2,</italic>
###xml 1021 1025 1021 1025 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3</italic>
###xml 1027 1035 1027 1035 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
###xml 1070 1074 1070 1074 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 1177 1182 1177 1182 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 1221 1225 1221 1225 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MAG1</italic>
###xml 1286 1294 1286 1294 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
The clustering analysis suggested additional novel functional interactions. We focused on one particular cluster within the dataset that included five genes: MPH1, SHU1, SHU2, CSM2, and PSY3. The latter four genes encode proteins that physically interact with one another and belong to a single epistasis group that appears to operate in a branch of HRR [64,65]. MPH1 was also shown to be epistatic with members of the HRR pathway [66], and the Mph1 protein, as predicted by its amino acid sequence, was recently shown to possess DNA helicase activity [67]. To our knowledge, however, no direct functional link between MPH1 and the other four genes has been reported. To test whether such a link exists, as suggested by our clustering analysis, we generated double mutants between MPH1 and each of the other four genes and measured the sensitivity of these strains to MMS. We found that single and double deletion strains exhibited similar sensitivity to MMS, indicating that MPH1 is epistatic with SHU1, SHU2, CSM2, and PSY3 (Figure 4C). Conversely, the addition of an MPH1 deletion to strains carrying deletions known to compromise other defined DNA-damage pathways, such as MUS81 (stalled replication-fork repair) and MAG1 (base excision repair), exacerbated the sensitivity to MMS (Figure 4C).
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
The high level of scrutiny paid to the DDR in yeast and other model organisms has yielded a wealth of data. In this study, we set out to address two aims. First, we sought to collect a sufficient number of fitness-profile signatures for compounds with similar mechanisms of action. This would allow us to test whether we could identify differences in compound profiles that might provide correlative insight into their diverse clinical efficacy. Second, we aimed to develop a standard assay platform, including all protocols and strains so that they can be exported to any laboratory. We believe that such a standard set of protocols will provide a powerful resource to the entire community and will allow for the development of a centralized database for the exchange of information.
###end p 39
###begin p 40
###xml 629 637 629 637 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g001">Figure 1</xref>
###xml 1265 1269 1265 1269 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSO2</italic>
###xml 1489 1497 1489 1497 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g003">Figure 3</xref>
###xml 1597 1605 1597 1605 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
###xml 43 48 <span type="species:ncbi:4932">yeast</span>
###xml 415 420 <span type="species:ncbi:4932">yeast</span>
While classical forward genetic screens in yeast have been instrumental in identifying important components of the DDR, it is unlikely that saturation across the genome has been achieved. In contrast to traditional genetic analysis, the approach employed here enabled the systematic interrogation of the comprehensive set of all 4,758 homozygous deletion strains, representing nearly all non-essential genes in the yeast genome. Furthermore, because the fitness-defect scores obtained with this method display a continuous range of sensitivity and these sensitivities correlate well with independently measured growth rates (see Figure 1B), genes can be ranked according to their relative importance in conferring resistance to a given compound. This provides a high level of resolution and allows distinctions to be made between functionally related compounds, even in cases where the genetic elements required for fitness largely overlap. For example, cisplatin, oxaliplatin, and carboplatin are structurally related chemotherapeutic drugs and, for each, their cytotoxicity is attributed primarily to their ability to induce ICLs. Predictably, fitness profiling of each compound identified the major pathways important for resistance to DNA cross-linking agents (PSO2/NER, HRR, and PRR). The fitness profile for carboplatin, however, was unique among the platinum-based compounds in that PRR was found to hold far greater importance in conferring resistance than the other pathways (see Figure 3). Carboplatin's distinctive profile is also apparent upon hierarchical clustering of the data (see Figure 4A), and could potentially reflect differences in the spectrum of structural damage to DNA or in cell-cycle-specific reactivity of the drug.
###end p 40
###begin p 41
###xml 227 229 227 229 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b68">68</xref>
###xml 691 698 691 698 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t001">Table 1</xref>
Although DNA-targeting drugs are typically viewed as non-specific, the cellular response to both diverse and functionally similar DNA-damaging agents is clearly distinct as is evidenced by their specific clinical applications [68]. It is important to note that most of these agents were used before their mechanism of action had been defined, and their effectiveness is still defined empirically. Given this fact and the fact that DNA will remain an excellent therapeutic oncology target, particularly as more selective and less toxic compounds are developed, high-throughput assays capable of defining drug action will undoubtedly prove useful. In this study, we used 12 compound profiles (Table 1) to define a benchmark from which the application of this assay to novel DNA-damaging compounds can be compared.
###end p 41
###begin p 42
###xml 541 548 541 548 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="pgen-0010024-t002">Table 2</xref>
###xml 661 663 661 663 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b69">69</xref>
###xml 1429 1437 1429 1437 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g002">Figure 2</xref>
Because the measured sensitivity of each strain in a given profile is a continuum of sensitivity as measured by growth inhibition, it is difficult to gauge the point at which fitness-defect scores cease to reflect significant defects in growth. We therefore sought to confirm the sensitivity detected in competitive pools by growing individual strains +/- the compound mechlorethamine. We found that 88% of the 233 strains most sensitive to mechlorethamine (based on rank) were also found to be sensitive in our individual growth assay (see Table 2). Thus, our assay has the advantage of having a measurable FDR that appears much lower than our calculated FDR [69]. This result is significant on several levels. First, we found 34 uncharacterized genes suggesting, as predicted, that our understanding of the DDR is still incomplete. Second, these results suggest that by choosing a stringent significance cut-off, we have likely missed other DDR genes, and the raw data from these screens should provide a rich data source for further analysis. Added to this complexity is our observation that several strains exhibit compound sensitivity only following extended drug exposure. By conducting our assay for both five and 20 generations of growth, we have gleaned a more comprehensive representation of the DDR. This enabled us to establish definitively a role for five checkpoint genes in conferring resistance to cisplatin (see Figure 2)-an observation for which there has been no consensus in the literature.
###end p 42
###begin p 43
###xml 497 502 <span type="species:ncbi:4932">yeast</span>
Our assay is distinct from expression studies, where an equivalent confirmation assay would represent hundreds of Northern blots or quantitative PCR assays to verify expression changes. In addition, expression arrays do not allow a ranking of genes as it is not clear how or if the magnitude of expression change is biologically significant. The fact that our assay allows a ranking of sensitivities, and confirmation of this ranking, makes it distinct from several colony-based studies using the yeast deletion collection. These solid-media assays for sensitivity are not highly quantitative, though spot-dilution confirmation does allow some measure of relative sensitivities.
###end p 43
###begin p 44
###xml 227 229 227 229 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b70">70</xref>
###xml 654 658 654 658 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 668 685 668 685 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU1, SHU2, CSM2,</italic>
###xml 690 694 690 694 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3</italic>
###xml 873 875 873 875 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b65">65</xref>
###xml 876 878 876 878 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b66">66</xref>
###xml 1110 1115 <span type="species:ncbi:4932">yeast</span>
In summary, despite significant advances in the breadth and depth of our understanding of the DDR, additional cell-based analyses are required before we can claim to fully understand DNA replication, recombination, and repair [70]. We believe that a new theme has emerged in these studies, however, in that the combined use of chemicals with genetic deletions can define functional groups that, in the absence of compound, would not be uncovered. For example, hierarchical clustering of the most highly sensitive strains identified using a combination of chemical and genetic perturbations successfully predicted novel epistatic interactions between the MPH1 gene and SHU1, SHU2, CSM2, and PSY3. Even though they comprise a major defense mechanism against several DNA-damaging agents, a role for these five gene products in a branch of HRR is only now beginning to emerge [65,66]. Further analysis of this dataset will undoubtedly uncover additional functional relationships whose discovery has thus far remained elusive. Finally, increased use (and increased availability) of chemical inhibitors to probe the yeast deletion collection should provide a more comprehensive, contextual understanding of cellular physiology.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
Reagents.
###end title 46
###begin p 47
Cisplatin, carboplatin, oxaliplatin, psoralen, angelicin, streptozotocin, 2-DMAEC, mechlorethamine, MMS, camptothecin, and 4-NQO were purchased from Sigma-Aldrich (St. Louis, Missouri, United States). Mitomycin C was purchased from Calbiochem (San Diego, California, United States). Each of these compounds was dissolved in DMSO, aliquoted, and stored at -20 degreesC until use, with the exception of cisplatin, which was used immediately following resuspension, and carboplatin, oxaliplatin, and 2-DMAEC, which were dissolved directly in YPD media at the time of the experiment.
###end p 47
###begin title 48
Strains and media.
###end title 48
###begin p 49
###xml 35 37 35 37 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b71">71</xref>
###xml 38 40 38 40 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b72">72</xref>
###xml 147 155 141 149 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-st003">Table S3</xref>
###xml 266 268 260 262 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b73">73</xref>
###xml 294 297 288 291 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">nat</italic>
###xml 301 304 295 298 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">hph</italic>
###xml 399 401 393 395 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b74">74</xref>
###xml 531 533 525 527 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b75">75</xref>
###xml 534 536 528 530 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b76">76</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 183 188 <span type="species:ncbi:4932">yeast</span>
Yeast was maintained in YPD media [71,72] at 30 degreesC unless stated otherwise. Strains used for individual analysis in this study are listed in Table S3 and were obtained from the yeast deletion collection or constructed de novo using PCR-based gene replacement [73]. Using this method, the nat or hph genes, conferring resistance to the antibiotics nourseothricin or hygromycin B, respectively [74], were PCR-amplified from plasmids and transformed into the appropriate background strain using a modified LiOAc-based protocol [75,76]. Transformants were selected on YPD containing antibiotic (100 mug/ml nourseothricin or 300 mug/ml hygromycin B), and successful gene-replacement events were verified by PCR.
###end p 49
###begin title 50
Deletion-pool construction and growth.
###end title 50
###begin p 51
###xml 59 61 59 61 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b22">22</xref>
###xml 234 237 227 230 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 837 839 829 831 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b23">23</xref>
The homozygous deletion pool was constructed as described [22] and stored in 20-mul aliquots at -80 degreesC. For the five-generation experiments, aliquots of the pool were thawed and diluted in YPD to an optical density at 600 nm (OD600) of 0.0625 and a final volume of 700 mul. Compound was then added and the pool was grown for five generations in a Tecan GENios microplate reader (Tecan, Durham, North Carolina, United States). For the 20-generation experiments, the thawed pool was first recovered for ten generations of logarithmic growth, diluted as above, and grown in the presence of compound over 20 generations. Cells were maintained in logarithmic phase by robotically diluting cultures every five doublings using a Packard Multiprobe II four-probe liquid-handling system (PerkinElmer, Wellesley, California, United States) [23].
###end p 51
###begin p 52
###xml 179 182 179 182 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
Experiments involving the two UVA light-activated compounds (psoralen and angelicin) were performed as described above with the following modifications: the pool was diluted to OD600 of 0.625 and compound was added to 70 mul of this cell suspension, which was then exposed to UVA light via a handheld UVA lamp (Ambion, Austin, Texas, United States) for 15 min. Following irradiation, cells were diluted 10x with YPD to a final volume of 700 mul and grown as described above.
###end p 52
###begin title 53
Genomic DNA preparation, PCR, and microarray hybridization.
###end title 53
###begin p 54
###xml 110 121 110 121 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd003">Datasets S3</xref>
###xml 126 128 126 128 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd004">S4</xref>
###xml 130 141 130 141 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd008">Protocol S3</xref>
###xml 144 146 144 146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b23">23</xref>
Genomic DNA preparation, PCR amplification of molecular tags, and microarray hybridization were as described (Datasets S3 and S4; Protocol S3) [23].
###end p 54
###begin title 55
Data analysis.
###end title 55
###begin p 56
###xml 783 784 783 784 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1034 1035 1034 1035 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1278 1280 1278 1280 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b28">28</xref>
###xml 1281 1283 1281 1283 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b29">29</xref>
Fitness-defect scores were calculated for each strain in the pool for each experiment. These scores are based on a tag-specific algorithm that takes into account the intensities of each tag on the experimental array and the corresponding intensities on a set of control arrays performed on the pool without compound (the control set). The majority of strains carry four tags that hybridize to the array: upstream tag (uptag), uptag antisense, downstream tag (dntag), and dntag antisense. The tag intensities are log transformed, mean normalized, and the intensities of the two strands of each tag are averaged into a single value for each tag. Next, a mean and standard deviation are calculated for the uptag and dntag intensities for each strain across the set of control arrays. A z-score for upstream and downstream tags for each strain is then calculated by taking the difference of the average intensities between the control and treatment and dividing by the standard deviation of the control-set intensities. The result is two z-score values for the upstream and downstream tags; these are then averaged into a single fitness-defect score for the strain. A significance cut-off for each experiment was determined by calculating the score cut-off required for a 0.05 FDR [28,29].
###end p 56
###begin title 57
Clustering analysis.
###end title 57
###begin p 58
###xml 367 377 367 377 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd005">Dataset S5</xref>
Hierarchical clustering analysis was performed with Cluster 3.0 () in Windows and Linux and visualized using Java Treeview () and slcview (http://slcview.stanford.edu). Clustering along both experiment and gene axes was performed on the calculated fitness-defect scores (as described above) using average linkage and Spearman's rank correlation as a distance metric (Dataset S5).
###end p 58
###begin title 59
Confirmations of individual strain growth rates.
###end title 59
###begin p 60
###xml 112 115 112 115 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 478 481 477 480 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 593 594 588 589 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 11 16 <span type="species:ncbi:4932">yeast</span>
Individual yeast strains were first grown to saturation for approximately 20 h. Cells were then diluted to an OD600 of 0.02 in a final volume of 100 mul using a Biomek FX Laboratory Automation Workstation (Beckman Coulter, Allendale, New Jersey, United States). Normalized cultures were grown in 96-well plates (Nunc, Rochester, New York, United States) in Tecan GENios microplate readers (Tecan) for up to 30 h. The growth rate of each culture was monitored by measuring the OD600 every 15 min and calculating the average doubling time (AvgG). AvgG was calculated by recording the time (Deltat) from the start of growth until the optical density of the culture reached the calibrated five-generation point (OD5g) and dividing this by the number of generations, i.e., five. If the culture did not reach OD5g, AvgG was calculated by using a binomial search to determine the fractional generations of the optical density at the end of the growth (ODf), assuming an exponential growth rate, then dividing the time to ODf by the generations calculated.
###end p 60
###begin p 61
###xml 155 159 151 155 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">mech</sub>
###xml 166 170 162 166 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">DMSO</sub>
We defined the sensitivity to mechlorethamine of each individual strain as the difference between the AvgG in mechlorethamine and in DMSO (DeltaAvgG = AvgGmech - AvgGDMSO). Individual deletion strains were scored as sensitive to mechlorethamine if this difference was greater than that of wild-type +/- the standard deviation calculated from 18 wild-type replicates.
###end p 61
###begin title 62
Viability assays.
###end title 62
###begin p 63
Selected strains were grown for five generations in the presence of compound and cells collected. Cells were transferred to 96-well plates and 5-fold dilutions were prepared. These dilutions were then "stamped" onto YPD plates using a pintool calibrated to deliver 5 mul. Cells were then allowed to form colonies for 2 d at 30 degreesC.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
The supporting files are also available in a searchable format at .
###end p 65
###begin title 66
Analyzed Microarray Data
###end title 66
###begin p 67
Calculated fitness-defect scores for each microarray experiment are presented.
###end p 67
###begin p 68
(7.2 KB XLS)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin title 70
Complete Set of Individual Strain Growth-Curve Data
###end title 70
###begin p 71
Each strain has three growth curves corresponding to growth in 1% DMSO, 31.3 muM mechlorethamine, and 62.5 muM mechlorethamine, respectively.
###end p 71
###begin p 72
(1.7 MB PNG)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin title 74
Unanalyzed, Raw Microarray Data from Affymetrix Software, Part 1
###end title 74
###begin p 75
This file contains 18 .cel files output from Affymetrix GeneChip operating system; these files constitute half of the total microarray dataset.
###end p 75
###begin p 76
(9.2 MB ZIP)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin title 78
Unanalyzed, Raw Microarray Data from Affymetrix Software, Part 2
###end title 78
###begin p 79
This file contains 18 .cel files output from Affymetrix GeneChip Operating System; these files constitute half of the total microarray dataset.
###end p 79
###begin p 80
(8.5 MB ZIP)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin title 82
###xml 51 59 51 59 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
Files Containing Cluster Output Used in Generating Figure 4A
###end title 82
###begin p 83
###xml 94 102 94 102 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="pgen-0010024-g004">Figure 4</xref>
These text files can be opened by clustergram-viewing software to browse the cluster shown in Figure 4A.
###end p 83
###begin p 84
(24 KB TXT)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
###xml 41 51 41 51 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd001">Dataset S1</xref>
Document Describing the Data Included in Dataset S1
###end title 86
###begin p 87
(26 KB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin title 89
###xml 41 51 41 51 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd002">Dataset S2</xref>
Document Describing the Data Included in Dataset S2
###end title 89
###begin p 90
(24 KB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin title 92
###xml 41 52 41 52 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd003">Datasets S3</xref>
###xml 57 59 57 59 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="pgen-0010024-sd004">S4</xref>
Document Describing the Data Included in Datasets S3 and S4
###end title 92
###begin p 93
(84 KB DOC)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin title 95
Strains Significantly Sensitive in Two or More 20-Generation Experiments that Exhibit Greater Sensitivity in Long-Term Drug Exposure
###end title 95
###begin p 96
(61 KB DOC)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin title 98
Number of Times Strains Were Calculated as Significantly Sensitive for Each Drug Condition and Length of Drug Exposure
###end title 98
###begin p 99
(80 KB XLS)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin title 101
Individual Strains Used in this Study
###end title 101
###begin p 102
(39 KB DOC)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin title 104
Accession Numbers
###end title 104
###begin p 105
###xml 88 92 88 92 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">CSM2</italic>
###xml 103 107 103 107 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">DDC1</italic>
###xml 118 122 118 122 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ELG1</italic>
###xml 133 137 133 137 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LTE1</italic>
###xml 148 152 148 152 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MAG1</italic>
###xml 163 167 163 167 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MEC3</italic>
###xml 178 182 178 182 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS1</italic>
###xml 193 197 193 197 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS4</italic>
###xml 208 212 208 212 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 223 228 223 228 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MRE11</italic>
###xml 239 244 239 244 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 255 259 255 259 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSO2</italic>
###xml 270 274 270 274 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3</italic>
###xml 285 289 285 289 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD1</italic>
###xml 300 304 300 304 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD2</italic>
###xml 315 319 315 319 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD4</italic>
###xml 330 334 330 334 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD5</italic>
###xml 345 349 345 349 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD6</italic>
###xml 360 364 360 364 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD9</italic>
###xml 375 380 375 380 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD10</italic>
###xml 391 396 391 396 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD14</italic>
###xml 407 412 407 412 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD17</italic>
###xml 423 428 423 428 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD18</italic>
###xml 439 444 439 444 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD24</italic>
###xml 455 460 455 460 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD50</italic>
###xml 471 476 471 476 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD51</italic>
###xml 487 492 487 492 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD52</italic>
###xml 503 508 503 508 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD54</italic>
###xml 519 524 519 524 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD55</italic>
###xml 535 540 535 540 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD57</italic>
###xml 551 556 551 556 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD59</italic>
###xml 567 571 567 571 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV1</italic>
###xml 582 586 582 586 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV3</italic>
###xml 597 601 597 601 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV7</italic>
###xml 612 616 612 616 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RMD7</italic>
###xml 627 633 627 633 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RTT101</italic>
###xml 644 650 644 650 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RTT107</italic>
###xml 661 665 661 665 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU1</italic>
###xml 676 680 676 680 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU2</italic>
###xml 691 698 691 698 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YDR291W</italic>
###xml 709 716 709 716 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YKL075C</italic>
###xml 727 734 727 734 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YLR426W</italic>
###xml 745 752 745 752 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">YMR073C</italic>
###xml 767 771 767 771 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">XRS2</italic>
Swiss-Prot () accession numbers for the strains discussed in this paper are as follows: CSM2 (P40465), DDC1 (Q08949), ELG1 (Q12050), LTE1 (P07866), MAG1 (P22134), MEC3 (Q02574), MMS1 (Q06211), MMS4 (P38257), MPH1 (P40562), MRE11 (P32829), MUS81 (Q04149), PSO2 (P30620), PSY3 (Q12318), RAD1 (P06777), RAD2 (P07276), RAD4 (P14736), RAD5 (P32849), RAD6 (P06104), RAD9 (P14737), RAD10 (P06838), RAD14 (P28519), RAD17 (P48581), RAD18 (P10862), RAD24 (P32641), RAD50 (P12753), RAD51 (P25454), RAD52 (P06778), RAD54 (P32863), RAD55 (P38953), RAD57 (P25301), RAD59 (Q12223), REV1 (P12689), REV3 (P14284), REV7 (P38927), RMD7 (P40056), RTT101 (P47050), RTT107 (P38850), SHU1 (P38751), SHU2 (P38957), YDR291W (Q05549), YKL075C (P36083), YLR426W (Q06417), YMR073C (Q04772), and XRS2 (P33301).
###end p 105
###begin p 106
We thank Grant Brown for critical comments and advice on the manuscript. WL was supported by the Stanford Genome Training Program. RPS was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. AA and PF were funded by a grant from the Howard Hughes Medical Institute. This work was supported by a grant from the National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering.
###end p 106
###begin title 107
Abbreviations
###end title 107
###begin p 108
DNA-damage response
###end p 108
###begin p 109
2-dimethylaminoethyl chloride
###end p 109
###begin p 110
dimethyl sulfoxide
###end p 110
###begin p 111
false-discovery rate
###end p 111
###begin p 112
homologous recombination repair
###end p 112
###begin p 113
interstrand cross-link
###end p 113
###begin p 114
methyl methanesulfonate
###end p 114
###begin p 115
nucleotide excision repair
###end p 115
###begin p 116
4-nitroquinoline-1-oxide
###end p 116
###begin p 117
post-replication repair
###end p 117
###begin p 118
translesion DNA synthesis
###end p 118
###begin p 119
###xml 0 5 <span type="species:ncbi:4932">yeast</span>
yeast extract/peptone/dextrose
###end p 119
###begin title 120
References
###end title 120
###begin article-title 121
How nucleotide excision repair protects against cancer
###end article-title 121
###begin article-title 122
The DNA damage response: Putting checkpoints in perspective
###end article-title 122
###begin article-title 123
Cell-cycle checkpoints and cancer
###end article-title 123
###begin article-title 124
###xml 62 67 <span type="species:ncbi:4932">yeast</span>
Break-induced replication: A review and an example in budding yeast
###end article-title 124
###begin article-title 125
Multiple pathways process stalled replication forks
###end article-title 125
###begin article-title 126
Aneuploidy and cancer
###end article-title 126
###begin article-title 127
Microsatellite instability: Marker of a mutator phenotype in cancer
###end article-title 127
###begin article-title 128
Cancer genes and the pathways they control
###end article-title 128
###begin article-title 129
Molecular mechanisms of drug resistance
###end article-title 129
###begin article-title 130
###xml 59 83 59 83 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 59 83 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Isolation and characterization of MMS-sensitive mutants of Saccharomyces cerevisiae
###end article-title 130
###begin article-title 131
###xml 95 100 <span type="species:ncbi:4932">yeast</span>
The isolation, genetics and survival characteristics of ultraviolet light-sensitive mutants in yeast
###end article-title 131
###begin article-title 132
A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage
###end article-title 132
###begin article-title 133
###xml 24 48 24 48 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 24 48 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity
###end article-title 133
###begin article-title 134
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
Genes required for ionizing radiation resistance in yeast
###end article-title 134
###begin article-title 135
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents
###end article-title 135
###begin article-title 136
###xml 83 88 <span type="species:ncbi:4932">yeast</span>
Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast
###end article-title 136
###begin article-title 137
Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways
###end article-title 137
###begin article-title 138
Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C
###end article-title 138
###begin article-title 139
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Functional profiling of the Saccharomyces cerevisiae genome
###end article-title 139
###begin article-title 140
###xml 35 48 35 48 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 35 48 <span type="species:ncbi:4932">S. cerevisiae</span>
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis
###end article-title 140
###begin article-title 141
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
Systematic screen for human disease genes in yeast
###end article-title 141
###begin article-title 142
###xml 86 91 <span type="species:ncbi:4932">yeast</span>
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
###end article-title 142
###begin article-title 143
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Functional profiling of the Saccharomyces cerevisiae genome
###end article-title 143
###begin article-title 144
###xml 70 75 <span type="species:ncbi:4932">yeast</span>
Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast
###end article-title 144
###begin article-title 145
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast genomics and proteomics in drug discovery and target validation
###end article-title 145
###begin article-title 146
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping
###end article-title 146
###begin article-title 147
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents
###end article-title 147
###begin article-title 148
Large-scale simultaneous hypothesis testing: The choice of a null hypothesis
###end article-title 148
###begin article-title 149
Controlling the false discovery rate-A practical and powerful approach to multiple testing
###end article-title 149
###begin article-title 150
Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair
###end article-title 150
###begin article-title 151
###xml 28 52 28 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage
###end article-title 151
###begin article-title 152
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Mec1p is essential for phosphorylation of the yeast DNA damage checkpoint protein Ddc1p, which physically interacts with Mec3p
###end article-title 152
###begin article-title 153
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Rad17/Mec3/Ddc1: A sliding clamp for the DNA damage checkpoint
###end article-title 153
###begin article-title 154
###xml 88 112 88 112 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 88 112 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae
###end article-title 154
###begin article-title 155
###xml 0 13 0 13 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 0 13 <span type="species:ncbi:4932">S. cerevisiae</span>
S. cerevisiae has three pathways for DNA interstrand crosslink repair
###end article-title 155
###begin article-title 156
DNA adducts from chemotherapeutic agents
###end article-title 156
###begin article-title 157
Repair of DNA interstrand cross-links
###end article-title 157
###begin article-title 158
Mitomycin C: Small, fast and deadly (but very selective)
###end article-title 158
###begin article-title 159
Efficient formation of a crosslinkable HMT monoadduct at the Kpn I recognition site
###end article-title 159
###begin article-title 160
###xml 105 129 105 129 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 105 129 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Interactions between mutations for sensitivity to psoralen photoaddition (pso) and to radiation (rad) in Saccharomyces cerevisiae
###end article-title 160
###begin article-title 161
###xml 2 7 <span type="species:ncbi:4932">yeast</span>
A yeast mutant specifically sensitive to bifunctional alkylation
###end article-title 161
###begin article-title 162
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
UV mutagenesis in radiation-sensitive strains of yeast
###end article-title 162
###begin article-title 163
###xml 46 70 46 70 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 46 70 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae
###end article-title 163
###begin article-title 164
DNA damage-induced mutation: Tolerance via translesion synthesis
###end article-title 164
###begin article-title 165
###xml 50 74 50 74 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 50 74 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Tying up loose ends: Nonhomologous end-joining in Saccharomyces cerevisiae
###end article-title 165
###begin article-title 166
Functional overlap between Sgs1-Top3 and the Mms4-Mus81 endonuclease
###end article-title 166
###begin article-title 167
The fuss about Mus81
###end article-title 167
###begin article-title 168
Cellular processing of platinum anticancer drugs
###end article-title 168
###begin article-title 169
Genotoxicity of streptozotocin
###end article-title 169
###begin article-title 170
Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents
###end article-title 170
###begin article-title 171
In vitro DNA reaction with an ultimate carcinogen model of 4-nitroquinoline-1-oxide: The 4-acetoxyaminoquinoline-1-oxide. Enzymatic degradation of the modified DNA
###end article-title 171
###begin article-title 172
###xml 99 104 <span type="species:ncbi:4932">yeast</span>
Deletion of the MAG1 DNA glycosylase gene suppresses alkylation-induced killing and mutagenesis in yeast cells lacking AP endonucleases
###end article-title 172
###begin article-title 173
###xml 94 110 94 110 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 94 110 <span type="species:ncbi:562">Escherichia coli</span>
Cloning a eukaryotic DNA glycosylase repair gene by the suppression of a DNA repair defect in Escherichia coli
###end article-title 173
###begin article-title 174
Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
###end article-title 174
###begin article-title 175
###xml 82 95 82 95 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces</italic>
Fungal BLAST and model organism BLASTP best hits: New comparison resources at the Saccharomyces Genome Database (SGD)
###end article-title 175
###begin article-title 176
###xml 139 163 139 163 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 139 163 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Systematic identification, classification, and characterization of the open reading frames which encode novel helicase-related proteins in Saccharomyces cerevisiae by gene disruption and Northern analysis
###end article-title 176
###begin article-title 177
###xml 51 56 <span type="species:ncbi:4932">yeast</span>
Global analysis of protein localization in budding yeast
###end article-title 177
###begin article-title 178
###xml 16 40 16 40 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 16 40 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The proteome of Saccharomyces cerevisiae mitochondria
###end article-title 178
###begin article-title 179
###xml 70 94 70 94 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 70 94 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Large-scale functional genomic analysis of sporulation and meiosis in Saccharomyces cerevisiae
###end article-title 179
###begin article-title 180
###xml 44 68 44 68 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 44 68 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance
###end article-title 180
###begin article-title 181
###xml 43 67 43 67 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 43 67 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Molecular cloning of chromosome I DNA from Saccharomyces cerevisiae: Isolation of the MAK16 gene and analysis of an adjacent gene essential for growth at low temperatures
###end article-title 181
###begin article-title 182
Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium
###end article-title 182
###begin article-title 183
###xml 51 56 <span type="species:ncbi:4932">yeast</span>
A comprehensive two-hybrid analysis to explore the yeast protein interactome
###end article-title 183
###begin article-title 184
###xml 41 65 41 65 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 41 65 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A genetic screen for top3 suppressors in Saccharomyces cerevisiae identifies SHU1, SHU2, PSY3, and CSM2-Four genes involved in error-free DNA repair
###end article-title 184
###begin article-title 185
###xml 6 10 6 10 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from homologous recombination, but not from postreplicative repair
###end article-title 185
###begin article-title 186
###xml 0 29 0 29 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae MPH1</italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae MPH1 gene, required for homologous recombination-mediated mutation avoidance, encodes a 3' to 5' DNA helicase
###end article-title 186
###begin article-title 187
DNA and its associated processes as targets for cancer therapy
###end article-title 187
###begin article-title 188
Significance analysis of microarrays applied to the ionizing radiation response
###end article-title 188
###begin article-title 189
DNA replication and recombination
###end article-title 189
###begin article-title 190
Cloning-free PCR-based allele replacement methods
###end article-title 190
###begin article-title 191
###xml 68 92 68 92 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 68 92 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae
###end article-title 191
###begin article-title 192
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure
###end article-title 192
###begin article-title 193
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
One-step transformation of yeast in stationary phase
###end article-title 193
###begin article-title 194
The GRID: The General Repository for Interaction Datasets
###end article-title 194
###begin article-title 195
###xml 0 6 <span type="species:ncbi:56262">Osprey</span>
Osprey: A network visualization system
###end article-title 195
###begin article-title 196
###xml 33 38 <span type="species:ncbi:4932">yeast</span>
Genetic activity of chemicals in yeast: DNA alterations and mutations induced by alkylating anti-cancer agents
###end article-title 196
###begin article-title 197
Mapping psoralen cross-links at the nucleotide level in mammalian cells: Suppression of cross-linking at transcription factor- or nucleosome-binding sites
###end article-title 197
###begin article-title 198
Alkylation damage in DNA and RNA-Repair mechanisms and medical significance
###end article-title 198
###begin article-title 199
###xml 69 72 <span type="species:ncbi:10116">rat</span>
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
###end article-title 199
###begin article-title 200
###xml 119 123 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice
###end article-title 200
###begin title 201
Figures and Tables
###end title 201
###begin title 202
Comparison of Individual Strain Analysis to Microarray Results
###end title 202
###begin p 203
###xml 216 219 215 218 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 384 405 383 404 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="sec" rid="s4">Materials and Methods</xref>
(A) Representative growth curves of 16 individual strains grown in the presence of solvent alone (DMSO, red curve) and 62.5 muM mechlorethamine (black curve). Growth was monitored by measuring the optical density (OD600) of cultures every 15 min for 30 h. The fitness of each strain was defined by the difference between the average doubling times in mechlorethamine and in DMSO (see Materials and Methods).
###end p 203
###begin p 204
###xml 570 571 570 571 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 571 572 571 572 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 606 607 606 607 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 614 615 614 615 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</italic>
(B) Correlation between growth rates of individual strains and microarray-based fitness estimates. The ratio of growth rates of the 186 individual homozygous deletion strains (the top 233 ranked mechlorethamine-sensitive strains as determined by three replicate microarray experiments minus 47 strains which exhibited a slow-growth phenotype when individually cultured in the absence of mechlorethamine) over an average wild-type growth rate are plotted on the x-axis against the average fitness-defect scores from three pool experiments on the y-axis. The correlation (R2 = 0.7462) is highly significant (p = 5.4e-57).
###end p 204
###begin title 205
The Effect of Exposure Duration on the Genetic Requirements for Resistance to DNA-Damaging Agents
###end title 205
###begin p 206
###xml 153 155 153 155 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b63">63</xref>
(A) Pie charts showing relative percentage of sensitive genes categorized into either "DNA metabolism", "unknown", or "other". All of the Gene Ontology [63] slim annotations (. Accessed February 17, 2005) are combined into "other" except for those classified in the unknown or DNA-metabolism category. The relative distributions of the mechlorethamine experiments are shown as a function of both time and gene rank.
###end p 206
###begin p 207
###xml 62 71 62 67 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad9&#916;</italic>
###xml 76 87 72 79 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad24&#916;,</italic>
###xml 491 500 482 487 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad9&#916;</italic>
###xml 505 515 492 498 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad24&#916;</italic>
###xml 181 186 <span type="species:ncbi:4932">Yeast</span>
(B) BY4743 (wild-type) and the DNA-damage-checkpoint mutants, rad9Delta and rad24Delta, were grown in the presence of 500 muM cisplatin over the course of ten population doublings. Yeast cultures were maintained in an exponential phase of growth by robotic dilution of cultures after five doublings into fresh media containing cisplatin. The growth of each deletion strain (black curve) is compared to that of BY4743 (red curve) between 0-5 (left) and 6-10 (right) population doublings. The rad9Delta and rad24Delta deletion strains exhibit accelerated grow rates in the first five generations, but by ten generations begin to demonstrate slow growth as compared to wild-type.
###end p 207
###begin p 208
###xml 153 156 153 156 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 539 584 539 568 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ddc1&#916;, rad24&#916;, rad17&#916;, mec3&#916;,</italic>
###xml 589 599 573 579 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad9&#916;.</italic>
###xml 711 743 691 711 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">swi4&#916;, yme1&#916;, rtf1&#916;,</italic>
###xml 748 757 716 721 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">gcs1&#916;</italic>
(C) Viability assay of strains treated with cisplatin or DMSO for five generations. Indicated strains were removed from cultures after they reached an OD600 of 2.0, and were diluted as shown. Strains were chosen based on the criteria that they did not show a growth defect at five generations but did show a growth defect at 20 generations. Dilutions were pinned onto YPD plates in a 5-fold concentration series. The wild-type parental diploid strain is compared to several diploid deletion strains that exhibited a decrease in viability: ddc1Delta, rad24Delta, rad17Delta, mec3Delta, and rad9Delta. In contrast, several of these strains showed little or no decrease in viability at five generations of growth: swi4Delta, yme1Delta, rtf1Delta, and gcs1Delta. This figure underscores the point that, despite the lack of an apparent growth defect in liquid culture, several deletion strains lose viability relatively rapidly when exposed to cisplatin.
###end p 208
###begin title 209
The Relative Importance of Well-Characterized DDR Modules for Resistance to Different DNA-Damaging Agents
###end title 209
###begin p 210
###xml 450 457 450 457 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(PSO2);</italic>
###xml 462 487 462 487 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD2, RAD4, RAD10, RAD1,</italic>
###xml 492 499 492 499 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD14);</italic>
###xml 504 517 504 517 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD6, RAD18,</italic>
###xml 522 528 522 528 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD5);</italic>
###xml 545 557 545 557 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(REV1, REV3,</italic>
###xml 562 568 562 568 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV7);</italic>
###xml 573 608 573 608 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(RAD57, RAD55, RAD51, RAD52, RAD54,</italic>
###xml 613 620 613 620 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD59);</italic>
###xml 653 659 653 659 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(MUS81</italic>
###xml 664 670 664 670 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MMS4).</italic>
Detailed examination of strains with mutations in DNA-damage-response genes. Each bar graph represents only strains that were found to be among the top 30 (or 250) most sensitive strains in that compound and are known to be members of a well-characterized DNA-damage-response pathway. The bars represent the median rank for genes in each of the gene groups listed in the visual key. The gene groups were defined in the following way: x-linking genes (PSO2); NER (RAD2, RAD4, RAD10, RAD1, and RAD14); PRR (RAD6, RAD18, and RAD5); error-prone TLS (REV1, REV3, and REV7); HRR (RAD57, RAD55, RAD51, RAD52, RAD54, and RAD59); stalled replication-fork repair (MUS81 and MMS4). Those compounds that form ICLs are labeled with an asterisk.
###end p 210
###begin title 211
Hierarchical Clustering of Genome-Wide Profiles Identifies Mechanistic Relationships Between Drugs and Functional Relationships Between Genes
###end title 211
###begin p 212
###xml 237 262 237 262 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD2, RAD4, RAD10, RAD14,</italic>
###xml 267 272 267 272 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD1&#8212;</italic>
###xml 296 300 296 300 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV1</italic>
###xml 305 310 305 310 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">REV3&#8212;</italic>
###xml 321 333 321 333 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD6, RAD18,</italic>
###xml 338 343 338 343 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD5&#8212;</italic>
###xml 378 391 378 391 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD57, RAD51,</italic>
###xml 396 402 396 402 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD54&#8212;</italic>
###xml 441 466 441 466 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">RAD9, RAD24, RAD17, DDC1,</italic>
###xml 471 476 471 476 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MEC3&#8212;</italic>
###xml 513 536 513 536 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU2, SHU1, CSM2, MPH1,</italic>
###xml 541 546 541 546 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3&#8212;</italic>
(A) Clustergram containing all strains significant in two or more array experiments. Raw fitness-defect values were hierarchically clustered using Spearman's rank correlation. Colored bars represent gene clusters of note, including NER (RAD2, RAD4, RAD10, RAD14, and RAD1-blue); error-prone TLS (REV1 and REV3-red); PRR (RAD6, RAD18, and RAD5-yellow); homologous recombination (RAD57, RAD51, and RAD54-green); cell-cycle checkpoint control (RAD9, RAD24, RAD17, DDC1, and MEC3-orange); and a cluster shown in (B) (SHU2, SHU1, CSM2, MPH1, and PSY3-magenta).
###end p 212
###begin p 213
###xml 166 184 166 184 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(SHU1, SHU2, CSM2,</italic>
###xml 189 194 189 194 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3)</italic>
###xml 250 252 250 252 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b65">65</xref>
###xml 253 255 253 255 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b77">77</xref>
###xml 256 258 256 258 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="pgen-0010024-b78">78</xref>
(B) Zoom view showing one cluster containing the class I NER genes and a second cluster containing several uncharacterized DNA-repair genes. Four of these five genes (SHU1, SHU2, CSM2, and PSY3) are known to encode proteins that physically interact [65,77,78].
###end p 213
###begin p 214
###xml 72 76 72 76 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 192 201 192 197 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">mph1&#916;</italic>
###xml 267 346 263 314 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">(shu1&#916;, shu2&#916;, csm2&#916;, psy3&#916;, mag1&#916;, mus81&#916;, rad51&#916;,</italic>
###xml 351 362 319 326 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rad54&#916;)</italic>
###xml 416 420 380 384 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 498 509 462 473 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1, MAG1,</italic>
###xml 514 519 478 483 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MUS81</italic>
###xml 595 600 559 564 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1,</italic>
###xml 698 702 662 666 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">MPH1</italic>
###xml 721 738 685 702 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">SHU1, SHU2, CSM2,</italic>
###xml 743 747 707 711 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">PSY3</italic>
(C) Individual growth curves of single and double deletion strains with MPH1 in 0.002% MMS. In all panels, the growth of wild-type (BY4741) is represented by the black curve and the growth of mph1Delta by the red curve. The growth of eight different deletion strains (shu1Delta, shu2Delta, csm2Delta, psy3Delta, mag1Delta, mus81Delta, rad51Delta, and rad54Delta) are shown in green, and double mutants, in which the MPH1 deletion is added to each of the above, are shown in blue. Double mutants of MPH1, MAG1, and MUS81 show additive or synergistic sensitivity to MMS, whereas double mutants of MPH1, with the four other genes in its cluster, show no additional sensitivity to MMS, suggesting that MPH1 is epistatic with SHU1, SHU2, CSM2, and PSY3.
###end p 214
###begin p 215
Summary of Compounds, with References Indicated
###end p 215
###begin p 216
Calculated FDR Versus Experimentally Measured FDR
###end p 216
###begin p 217
Comparison of the Average Ranked Sensitivity of Five DNA-Damage-Checkpoint Mutants from Experiments in which the Pooled Homozygous Deletion Collection Was Exposed to 500 muM Cisplatin for Either Five or 20 Generations
###end p 217
###begin p 218
###xml 0 20 0 20 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 218
###begin p 219
###xml 0 21 0 21 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Author contributions.</bold>
Author contributions. WL, RPS, CN, and GG conceived and designed the experiments. WL and RPS performed the experiments. PF and WL analyzed the data. MP designed the robotic software and built the robotics platform. APA and MIJ provided the analysis tools and assistance. WL, RPS, CN, and GG wrote the paper. RWD provided a nurturing environment and valuable intellectual insights.
###end p 219
###begin p 220
Citation: Lee W, St. Onge RP, Proctor M, Flaherty P, Jordan MI, et al. (2005) Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet 1(2): e24.
###end p 220

